Table of contents
June 2015 - Volume 74 - Suppl 2
- Speaker Presentations
- Health Professional welcome session
- WIN session 1
- Psoriatic arthritis - a clinical perspective
- Difficult vasculitis
- HOT session 1
- Do new anti-osteoporotic drugs have an additional effect on bone quality?
- Optimising the use of electronic information and technology in clinic and research
- Autoinflammatory diseases
- Co-stimulation: towards genuine immune modulation
- Estrogens: critical regulator of the immune response; implication for sex bias in the development of autoimmunity
- Training of rheumatology across Europe
- Get on the move with rheumatic and musculoskelettal disease
- Building sustainable relationships between patients and researchers
- Improving your graphs and tables for publication and presentation
- What is the impact of imaging on the management of rheumatoid arthritis?
- Calcinosis
- HOT session 2
- Pregnancy in rheumatic disease
- Searching for evidence to support clinical practice - using non-steroidals as an example
- From children to adults
- Computers in rheumatology - friends or foes?
- Food and the immune system
- Ethnicity - a blind spot within rheumatology?
- Measuring success - how to evaluate the impact of your campaign
- Capillaroscopy I
- Beyond GWA: functional genomics
- Inflammation and fatigue
- WIN session 2
- HOT session 3
- Championing work
- WIN session 3
- Perspectives on stratified medicine in RA
- Glucocorticoid sparing in non-RA rheumatic diseases
- HOT session 4
- Use and abuse of opioids in non-malignant pain
- Functioning measures of function: PROM's and CROM's in the light of the WHO ICF
- Dermatomyositis 1
- New players in lupus
- A painful joint - where is the pain coming from?
- International experience
- Cardiovascular risk assessment - getting to grips with the challenges
- Lost in the system - how to use innovative care to bring health services back to the patient
- WIN session 4
- Axial SpA: disease modification
- Clinically suspect arthralgia
- HOT session 5
- Regenerative rheumatology
- Work productivity as an outcome measure
- Dermatomyositis II
- The shared mechanisms of arthritis and atherosclerosis
- Imaging & structure of the immune system
- Being a researcher in the rheumatology world
- Innovations in healthcare - can you Google it?
- Who cares? Primary care focus
- Ultrasound advanced I
- ABC of biopsies: when to perform and how to interpret I
- Transition from chronic inflammation to cancer: the basic story
- Complement as a driver and target in inflammatory disease
- WIN session 5
- HOT session 6
- WIN session 6
- Therapeutic insights from early clinical studies in SLE
- Autoinflammatory disease
- HOT session 7
- Are we ready for RCTs in scleroderma? Importance of disease stratification and application of predictive markers
- Predicting the development of RA
- Other myopathies
- New insights in osteo-immunology
- New pathogenic aspects in vasculitis
- Evidence based medicine. To design and understand clinical trials and meta-analysis
- Social and work participation - research into practice
- What is new? Latest advances in treatment and management
- Capillaroscopy II
- WIN session 7
- Combination therapy with biologics in rheumatic diseases - what does the future hold?
- Polymyalgia rheumatica versus elderly onset rheumatoid arthritis: a diagnostic challenge
- HOT session 8
- Treatment and outcome measures in inflammatory myopathies. Update on pharmacological and physical therapy and how to assess
- From basic science: JIA pathogenesis
- Scleroderma mechanisms - new perspectives
- EULAR/EFIS session: Autoimmunity and inflammation in anti-checkpoint antibody therapies of cancer?
- The art of writing
- Fit to fight rheumatic and musculoskeletal diseases - how much exercise is beneficial and safe?
- Patient reported outcomes and the EULAR outcome measure toolkit
- Youth in action
- MRI I
- WIN session 8
- Comorbidities
- Diagnosis of back pain - suspicion of SpA
- HOT session 9
- Coagulation and rheumatology
- New challenges in clinical trials
- Juvenile localized scleroderma
- Autoimmune B-cells in human disease
- Bone phenotypes of osteoarthritis: towards personalised treatment
- Strategic decisions in a career
- Unlocking the mystery of health economics
- Family business
- MRI II
- WIN session 9
- Viral infections and biologics
- Poly-autoimmune diseases
- HOT session 10
- Treatment and prognosis for OA beyond the knee
- Quality indicators - a way to measure the quality of care
- Systemic sclerosis
- Microvesicles and intracellular transport
- Why psoriasis in arthritis
- The art of teaching rheumatology
- Breaking down barriers - implementing non pharmacological guidelines in clinical practice
- Taking control: success through empowerment and self-management
- Oral Presentations
- Psoriatic arthritis - a clinical perspective
- Do new anti-osteoporotic drugs have an additional effect on bone quality?
- Optimising the use of electronic information and technology in clinic and research
- Autoinflammatory diseases
- Co-stimulation: towards genuine immune modulation
- Training of rheumatology across Europe
- Get on the move with rheumatic and musculoskelettal disease
- Building sustainable relationships between patients and researchers
- What is the impact of imaging on the management of rheumatoid arthritis?
- Pregnancy in rheumatic disease
- Searching for evidence to support clinical practice - using non-steroidals as an example
- From children to adults
- Food and the immune system
- Ethnicity - a blind spot within rheumatology?
- Measuring success - How to evaluate the impact of your campaign
- Beyond GWA: functional genomics
- Abstract session: Developments in the treatment of RA
- Abstract session: SpA clinical
- Abstract session: Epidemiology and health services research
- Abstract session: SSc clinical and treatment
- PreS Abstract session: Clinical aspects of paediatric rheumatology
- Abstract session: The biology of RA
- Abstract session: SLE, Sjögren's, APS: etiology, pathogenesis, animal models
- Abstract session: SLE, Sjögren and APS: clinical aspects other than treatment
- HPR Abstract session I: Evidence based practice
- Abstract session: Osteoarthritis clinical aspects
- Championing work
- Abstract session: Adaptive immunology in rheumatic disease
- Abstract session: Emerging concepts in genomics and genetics
- Perspectives on stratified medicine in RA
- Use and abuse of opioids in non-malignant pain
- Functioning measures of function: PROM's and CROM's in the light of the WHO ICF
- Dermatomyositis 1
- New players in lupus
- A painful joint - where is the pain coming from?
- Cardiovascular risk assessment - getting to grips with the challenges
- Lost in the system - how to use innovative care to bring health services back to the patient
- Axial SpA: disease modification
- Regenerative rheumatology
- Work productivity as an outcome measure
- Dermatomyositis II
- The shared mechanisms of arthritis and atherosclerosis
- Imaging & structure of the immune system
- Being a researcher in the rheumatology world
- Innovations in healthcare - can you Google it?
- Who cares? Primary care focus
- Complement as a driver and target in inflammatory disease
- Abstract session: Comorbidities in RA
- Abstract session: SpA and PsA treatment
- Abstract session: RA prognosis, predictors, outcome
- Abstract session: SLE and Sjögren's: new treatment options
- PreS Abstract session: Basic aspects in paediatric rheumatology
- Abstract session: SpA and PsA basic and translational research
- Abstract session: SSc pathogenesis, etiology and animal models
- Abstract session: New insights into imaging
- HPR Abstract session II: Getting to grips with evidence
- Abstract session: Vasculitis
- PARE Abstract session
- Abstract session: Cartilage - bone - synovium
- Abstract session: Cytokines and inflammatory mediators
- Therapeutic insights from early clinical studies in SLE
- Are we ready for RCTs in scleroderma? Importance of disease stratification and application of predictive markers
- Predicting the development of RA
- Other myopathies
- New insights in osteo-immunology
- New pathogenic aspects in vasculitis
- Evidence based medicine. To design and understand clinical trials and meta-analysis
- Social and work participation - research into practice
- Treatment and outcome measures in inflammatory myopathies. Update on pharmacological and physical therapy and how to assess
- Cost effectiveness of biologics in RA (joint with clinical science?)
- From basic science: JIA pathogenesis
- Scleroderma mechanisms - new perspectives
- Fit to fight rheumatic and musculoskeletal diseases - how much exercise is beneficial and safe?
- Youth in action
- Comorbidities
- New challenges in clinical trials
- Juvenile localized scleroderma
- Autoimmune B-cells in human disease
- Bone phenotypes of osteoarthritis: towards personalised treatment
- Unlocking the mystery of health economics
- Family business
- Viral infections and biologics
- Treatment and prognosis for OA beyond the knee
- Quality indicators - a way to measure the quality of care
- Systemic sclerosis
- Microvesicles and intracellular transport
- Why psoriasis in arthritis
- The art of teaching rheumatology
- Breaking down barriers - implementing non pharmacological guidelines in clinical practice
- Taking control: success through empowerment and self-management
- Poster Presentations
- Genomics, genetics and epigenetics of rheumatic diseases
- Innate immunity in rheumatic diseases
- Rheumatoid arthritis - etiology, pathogenesis and animal models
- Rheumatoid arthritis - prognosis, predictors and outcome
- Rheumatoid arthritis - comorbidity and clinical aspects
- Rheumatoid arthritis - non biologic treatment and small molecules
- Spondyloarthritis - treatment
- Infection-related rheumatic diseases
- Vasculitis
- Fibromyalgia and pain in rheumatic diseases
- Epidemiology, health services and outcome research
- SLE, Sjögren's and APS - etiology, pathogenesis and animal models
- SLE, Sjögren's and APS - treatment
- Psoriatic arthritis
- Osteoarthritis
- Paediatric rheumatology
- Other orphan diseases
- Education
- Rehabilitation
- Adaptative immunity (T cells and B cells) in rheumatic diseases
- Rheumatoid arthritis - anti-TNF therapy
- Rheumatoid arthritis - other biologic treatment
- Spondyloarthritis - etiology, pathogenesis and animal models
- Spondyloarthritis - clinical aspects (other than treatment)
- Osteoporosis
- Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
- SLE, Sjögren's and APS - clinical aspects (other than treatment)
- Scleroderma, myositis and related syndromes - etiology, pathogenesis and animal models
- Scleroderma, myositis and related syndromes - clinical aspects and treatment
- Back pain, mechanical musculoskeletal problems, local soft tissue disorders
- Diagnostics and imaging procedures
- Cytokines and inflammatory mediators
- Cartilage, synovium and osteoimmunology
- Abstracts Accepted for Publication
- Genomics, genetics and epigenetics of rheumatic diseases
- Adaptative immunity (T cells and B cells) in rheumatic diseases
- Innate immunity in rheumatic diseases
- Cytokines and inflammatory mediators
- Cartilage, synovium and osteoimmunology
- Rheumatoid arthritis - etiology, pathogenesis and animal models
- Spondyloarthritis - etiology, pathogenesis and animal models
- SLE, Sjögren's and APS - etiology, pathogenesis and animal models
- Scleroderma, myositis and related syndromes - etiology, pathogenesis and animal models
- Basic science in paediatric rheumatology
- Rheumatoid arthritis - prognosis, predictors and outcome
- Rheumatoid arthritis - comorbidity and clinical aspects
- Rheumatoid arthritis - anti-TNF therapy
- Rheumatoid arthritis - other biologic treatment
- Rheumatoid arthritis - non biologic treatment and small molecules
- SLE, Sjögren's and APS - treatment
- SLE, Sjögren's and APS - clinical aspects (other than treatment)
- Vasculitis
- Scleroderma, myositis and related syndromes - clinical aspects and treatment
- Spondyloarthritis - treatment
- Spondyloarthritis - clinical aspects (other than treatment)
- Psoriatic arthritis
- Osteoarthritis
- Osteoporosis
- Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
- Infection-related rheumatic diseases
- Fibromyalgia and pain in rheumatic diseases
- Back pain, mechanical musculoskeletal problems, local soft tissue disorders
- Paediatric rheumatology
- Other orphan diseases
- Diagnostics and imaging procedures
- Epidemiology, health services and outcome research
- Rehabilitation
- Education
- Miscellaneous forms of clinical care
- Nursing
- Psychology/Social sciences
- Occupational therapy
- Nursing
- Psychology/Social sciences
- Physiotherapy
- Occupational therapy
- Miscellaneous forms of clinical care
- Psychosocial support
- Best practice campaigning
- Patient information and education
- Work and rehabilitation
- Arthritis research
- Physiotherapy